Novartis Heart Drug Shows Mixed Results
Novartis Heart Drug Shows Mixed Results
Filed under: drug treatment news
Serelaxin was given to patients upon hospitalization via a 48-hour infusion. The study failed to show that it kept patients alive or out of hospital longer than the standard treatment, meaning that it failed a secondary study goal to demonstrate the …
Read more on Wall Street Journal
Octomom Nadya Suleman leaves drug rehab to film music video
Filed under: drug treatment news
Octomom Nadya Suleman, who's currently in a 28-day drug rehab program, temporarily left treatment to film a spoof music video in Tennessee. Suleman, who's being treated for panic attacks, exhaustion and a Xanax dependency, has been in Tennessee …
Read more on Examiner.com
FDA approves new arthritis drug
Filed under: drug treatment news
U.S. regulators on Tuesday approved Pfizer Inc's Xeljanz treatment for rheumatoid arthritis, one of the company's most potentially lucrative experimental drugs, which is now poised to compete with Abbott Laboratories Inc's top-selling Humira. The U.S …
Read more on Fox News